On May 16th, Imperial Brands reported that their profit had increased thanks to successfully raising tobacco product prices to offset declining sales. The company also saw a nearly 20% increase in revenue from their next generation tobacco products (NGP).
Imperial Tobacco's adjusted operating profits grew by 0.8% to £1.6 billion ($2 billion) and revenue increased by 0.3% to £15.41 billion ($19.62 billion) in the six months ended on March 31st.
While the traditional cigarette market is decreasing, Imperial Tobacco has been able to increase its market share in the past six months by taking advantage of price increases. The company reported that in its five key markets - the United States, Australia, Spain, Germany, and the United Kingdom - its cigarettes experienced an additional 20 basis points of growth.
It is noteworthy that the next generation of products (NGP), including e-cigarettes and other categories, saw a revenue growth of nearly 20% in the first half of this fiscal year.
Reference:
The Imperial company is investing in alternative tobacco products and increasing prices in order to generate growth.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
